Haemonetics Corporation with ticker code (HAE) now have 7 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 115 and 90 calculating the average target price we see $104.57. Given that the stocks previous close was at $83.34 this now indicates there is a potential upside of 25.5%. The 50 day moving average now sits at $82.16 and the 200 day MA is $80.04. The company has a market cap of 4.24B. The stock price is currently at: 84.12 USD
The potential market cap would be $5,324,668,143 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 38.24, revenue per share of 23.01 and a 5.35% return on assets.
